The product may cause an incomplete staple line to be formed and, therefore, not provide expected control of the tissue.
Source facts
Action
The firm sent letters, dated 11/21/04, to all consignees.
Initiated
2004-11-21
Root cause
Other
Terminated
2008-10-29
Distribution
The product was distributed to hospitals and distributors throughout the United States and to foreign customers located in Korea, China, Republic of Singapore, Argentina, Italy, New Zealand, Austria, Canada, Australia, Brazil, United Arab Emirate, Thailand, Czech Republic, Sweden, Switzerland, Greece, Russia, India, Portugal, Israel, Poland, Hungary, and Uruguay.
Recall number
Z-0462-05
Recall status
Terminated
CDRH record ID
36037
FDA classified
2005-02-01
Recall event number
30516
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.